Bromide

Bromide

SCHEMBL1769810

CC[N+](C)(CC)CCOC.[Br-]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 4/20 0.39
CHRM4 known ✓ P08173 3/20 0.39
CHRM3 known ✓ P20309 3/20 0.39
CHRM2 known ✓ P08172 3/20 0.36
CHRM5 known ✓ P08912 1/20 0.33
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA7 P36544 1/20 0.34
CYP2D6 P10635 2/20 0.33
SIGMAR1 Q99720 1/20 0.33
BBOX1 O75936 1/20 0.33
SCN1A P35498 2/20 0.31
SCN2A Q99250 2/20 0.31
SCN3A Q9NY46 2/20 0.31
LMNA P02545 1/20 0.30
CYP1A2 P05177 1/20 0.30
KMT2A Q03164 1/20 0.30
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL272775 0.97 CHRM1 (0.36) CHRM1CHRM4CHRM3CHRM2CHRNB4
Iodide SCHEMBL1408228 0.94 CHRNB4 (0.38) CHRM1CHRM4CHRM3CHRM2CHRNB4
Fluoride Ion SCHEMBL15361775 0.94 CHRM1 (0.35) CHRM1CHRM4CHRM3CHRM2CHRNB4
Hydrochloric Acid SCHEMBL4146323 0.94 CHRM1 (0.35) CHRM1CHRM4CHRM3CHRM2CHRNB4
Water SCHEMBL15361514 0.94 CHRM1 (0.35) CHRM1CHRM4CHRM3CHRM2CHRNB4
Ammonia Solution, Strong SCHEMBL28074213 0.94 CHRM1 (0.35) CHRM1CHRM4CHRM3CHRM2CHRNB4
SCHEMBL16109018 0.92 CHRM4 (0.32) CHRM1CHRM4CHRM3CHRM2CHRNB4
Boric Acid SCHEMBL25291015 0.87 CHRM1 (0.36) CHRM1CHRM4CHRM3CHRM2CHRNB4
SCHEMBL17583835 0.87 BBOX1 (0.34) CHRM1CHRM4CHRM3CHRM2CHRNB4
SCHEMBL22264541 0.87 CHRM4 (0.33) CHRM1CHRM4CHRM3CHRM2CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117813334-A Onium salt, blocking agent dissociation catalyst for blocking isocyanate, blocked isocyanate composition containing blocking agent dissociation catalyst, thermosetting resin composition, cured product, and method for producing same 广荣化学株式会社 2024-04-02 CN disclosed
EP-4261973-A1 SELF-STANDING SOLID ELECTROLYTE FOR SOLID LITHIUM-AIR BATTERY CELLS AND METHOD OF PREPARATION THEREOF TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2023-10-18 EP disclosed
EP-3352293-A1 QUATERNARY AMMONIUM HALIDES WITH ETHER FUNCTIONAL GROUPS FOR USE AS BATTERY ELECTROLYTES Albemarle Corporation (US) 2018-07-25 EP disclosed
EP-3170789-B1 PRODUCTION PROCESS FOR FLUOROSULFONYLIMIDE AMMONIUM SALT NIPPON SODA CO (JP) 2018-04-18 EP disclosed
US-20170237129-A1 Quaternary Ammonium Halides With Ether Functional Groups For Use As Battery Electrolytes ALBEMARLE AMENDMENTS, LLC 2017-08-17 US disclosed
EP-3195398-A1 QUATERNARY AMMONIUM HALIDES WITH ETHER FUNCTIONAL GROUPS FOR USE AS BATTERY ELECTROLYTES Albemarle Corporation (US) 2017-07-26 EP disclosed
US-20170162898-A1 Quaternary Ammonium Halides With Ether Functional Groups For Use As Battery Electrolytes ALBEMARLE AMENDMENTS, LLC 2017-06-08 US disclosed
EP-3170789-A1 PRODUCTION PROCESS FOR FLUOROSULFONYLIMIDE SALT NIPPON SODA CO., LTD. (JP) 2017-05-24 EP disclosed
WO-2016028408-A1 QUATERNARY AMMONIUM HALIDES WITH ETHER FUNCTIONAL GROUPS FOR USE AS BATTERY ELECTROLYTES ALBEMARLE CORPORATION (US) 2016-02-25 WO disclosed
US-9242862-B2 Process for production of fluorosulfonylimide ammonium salt NIPPON SODA CO., LTD. (JP) 2016-01-26 US disclosed
US-20130323154-A1 PROCESS FOR PRODUCTION OF FLUOROSULFONYLIMIDE AMMONIUM SALT NIPPON SODA CO., LTD. (JP) 2013-12-05 US disclosed
EP-2660196-A1 MANUFACTURING METHOD FOR FLUOROSULFONYLIMIDE AMMONIUM SALT Nippon Soda Co., Ltd. (JP) 2013-11-06 EP disclosed
US-20130079504-A1 POLYSACCHARIDE GEL AND PROCESS FOR PRODUCING SAME JAPAN ATOMIC ENERGY AGENCY (JP) 2013-03-28 US disclosed
US-8366956-B2 Quaternary ammonium salt and composition, and electrochemical device OTSUKA CHEMICAL CO., LTD. (JP) 2013-02-05 US disclosed
US-20130004860-A1 QUATERNARY AMMONIUM SALT AND COMPOSITION, AND ELECTROCHEMICAL DEVICE STELLA CHEMIFA CORPORATION (JP) 2013-01-03 US disclosed
US-20110123873-A1 Quaternary ammonium salt and composition, and electrochemical device STELLA CHEMIFA CORPORATION (JP) 2011-05-26 US disclosed
US-7834197-B2 Quaternary ammonium salt, electrolyte, and electrochemical device OTSUKA CHEMICAL CO., LTD. (JP) 2010-11-16 US disclosed
EP-2172463-A1 Quaternary ammonium salt, electrolytic solution and electrochemical device Otsuka Chemical Co., Ltd. (JP) 2010-04-07 EP disclosed
US-20070042271-A1 Quaternary ammonium salt, electrolyte, and electrochemical device OTSUKA CHEMICAL CO., LTD. (JP) 2007-02-22 US disclosed
EP-1642894-A1 QUATERNARY AMMONIUM SALT, ELECTROLYTE, AND ELECTROCHEMICAL DEVICE OTSUKA CHEMICAL COMPANY, LIMITED (JP) 2006-04-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130323154-A1 PROCESS FOR PRODUCTION OF FLUOROSULFONYLIMIDE AMMONIUM SALT ASNS, NHERF1, NAAA CHRM1 4615/4885CHRM4 4512/4885CHRM3 4708/4885
US-20110123873-A1 Quaternary ammonium salt and composition, and electrochemical device DNMT3A, AFF4, AFF2 CHRM1 233/4885CHRM4 232/4885CHRM3 772/4885
US-20070042271-A1 Quaternary ammonium salt, electrolyte, and electrochemical device DNMT3A, NHERF1, SLC9A1 CHRM1 196/4885CHRM4 777/4885CHRM3 1349/4885
US-20130004860-A1 QUATERNARY AMMONIUM SALT AND COMPOSITION, AND ELECTROCHEMICAL DEVICE DNMT3A, AFF4, AFF2 CHRM1 233/4885CHRM4 232/4885CHRM3 772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.